Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 5:30 PM ET

Healthcare Equipment and Supplies

Company Overview of Bracco S.p.A.

Company Overview

Bracco S.p.A. discovers, develops, manufactures, and markets diagnostic imaging agents and solutions for various diagnostic modalities worldwide. It offers contrast agents, administration systems, medical devices, and injectors; prescription drugs, over-the-counter drugs, and food supplements via pharmacies; and oncological anatomopathology advisory, radio-therapeutic treatment, cancer diagnosis, and environmental health and safety services. The company provides customized prevention, diagnosis, rehabilitation, and personalized and therapeutic services. It offers its solutions portfolio for various modalities, including X-ray imaging, magnetic resonance imaging, contrast enhanced ultrasound,...

Via Egidio Folli 50- I

San Donato Milanese, MI 20134


Founded in 1927


39 02 21771


39 0221 77 21 77

Key Executives for Bracco S.p.A.

Chairman of The Board, Chief Executive Officer and President
Age: 74
Head of The Global Business Unit Imaging of Bracco Imaging
Director of Bracco Research SA
General Manager of Operations At Bracco Imaging Spa
Compensation as of Fiscal Year 2015.

Bracco S.p.A. Key Developments

Apricus Biosciences, Inc. Launches Vitaros, Topical Treatment for Erectile Dysfunction, or ED, in Italy by Bracco SpA

Apricus Biosciences, Inc. has announced the launch of Vitaros, a topical treatment for erectile dysfunction, or ED, in Italy by Bracco SpA. Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction, or ED, is also marketed under the trademark Vytaros in Belgium and Virirec in Spain. This is the seventh country in the European Union in which the product has been launched, including France, Italy, Germany, the UK, Spain, Belgium and Sweden. In total, Vitaros is currently approved under the European Decentralized Procedure ("DCP") in twenty-two countries, of which fourteen have further approved Vitaros for commercialization at the national phase level of the DCP approval process. As another contributor towards the positive momentum of commercialization by partners, which recently produced 103% growth in units quarter over quarter, Bracco plans to implement a strong promotional strategy targeted at physicians across Italy. In December 2010, Apricus signed an exclusive license agreement with Bracco to market Vitaros, in Italy, Vatican City and San Marino (the "Territory"). Under the terms of the agreement, Apricus has received $1.3 million in up-front and milestone payments from Bracco. Apricus is also eligible to receive milestone payments on future sales, plus double-digit tiered royalties based on Bracco's net sales of the product in the Territory. In exchange, Bracco has the exclusive right to commercialize Vitaros in the Territory. In addition, Bracco has agreed to certain minimum marketing commitments for Vitaros.

Similar Private Companies By Industry

Company Name Region
CIBA VISION S.r.l. Europe
Newmed s.r.l. Europe
QR s.r.l. Europe
Alliance Diagnostic s.r.l. Europe
Tecno Hospital S.r.l. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bracco S.p.A., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at